12/23
07:00 am
euda
EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen
High
Report
EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen
12/22
07:00 am
euda
EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem
High
Report
EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem
12/8
07:00 am
euda
EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem
Low
Report
EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem
12/5
09:42 am
euda
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement [Yahoo! Finance]
Medium
Report
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement [Yahoo! Finance]
12/5
09:30 am
euda
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement
Medium
Report
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement
10/23
09:00 am
euda
EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India
High
Report
EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India
10/20
09:00 am
euda
EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia
Low
Report
EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia
10/14
12:13 pm
euda
EUDA Health (NASDAQ:EUDA) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Neutral
Report
EUDA Health (NASDAQ:EUDA) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
10/3
03:35 pm
euda
EUDA Health (NASDAQ:EUDA) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
EUDA Health (NASDAQ:EUDA) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.